References
- 1. Ghauharali-Imami S, Bax M, Haasdijk A, et al. The impact of gender on long-term mortality in patients with multivessel disease after primary percutaneous coronary intervention. Neth Heart J. 2015;23:592-599.10.1007/s12471-015-0754-x
- 2. Loncar G, Barthelemy O, Berman E, et al. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention. Arch Cardiovasc Dis. 2015;108:554-562.10.1016/j.acvd.2015.06.001
- 3. Matejka J, Varvarovski I, Rozsival V, et al. Heart failure is the strongest predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Kardiol Pol. 2015; doi: 10.5603/KP.a2015.0115. [Epub ahead of print]10.5603/KP.a2015.0115
- 4. Jang JS, Spertus JA, Arnold SV, et al. Impact of Multivessel Revascularization on Health Status Outcomes in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. J Am Coll Cardiol. 2015;66:2104-2113.10.1016/j.jacc.2015.08.873
- 5. Barcan A, Kovacs I, Blendea C, Orzan M, Chitu M. Factors associated with in-hospital mortality in patients with acute coronary syndrome. Journal Cardiovasc Emerg. 2015:1(2):68-74.10.1515/jce-2015-0010
- 6. Ramanath VS, Eagle KA. Evidence-based medical therapy of patients with acute coronary syndromes. Am J Cardiovasc Drugs. 2007;7:95-116.10.2165/00129784-200707020-00002
- 7. Schehter M, Goldenberg I, Matetztki Slomi. Trends in mortality rates from acute coronary syndrome octogenarian patients in Israel during the period 2003-2013. J Am Coll Cardiol. 2015;65(10_S).10.1016/S0735-1097(15)60077-8